Dr Reddy's continues to see huge selling, down over 5%
The stock has fallen by over 20 percent in three days.
Nov 10, 2015, 13:14 PM IST
DRL says taking corrective actions after FDA warning letter
DRL shares on Monday stumbled by 3.44 percent over previous close to Rs 3,504.60 on BSE.
Nov 09, 2015, 21:12 PM IST
Dr Reddy's gets USFDA warning for 3 drug plants; stock tanks
The company hopes for a re-audit of the three plants by USFDA
Nov 06, 2015, 16:30 PM IST
Dr Reddy's tanks 14.5 pc on USFDA warning
Shares of drug firm Dr Reddy's Laboratories today plunged 14.5 per cent after the company said it has received a warning letter from the US health regulator over inadequate quality control procedures at its three drug manufacturing units in India.
Nov 06, 2015, 13:02 PM IST
Dr Reddy's Lab Q2 net profit rises 26% to Rs 722 crore
Aided by good sales growth coupled with new product launches, drug major Dr Reddy's Laboratories Thursday reported a 25.74 percent jump in consolidated net profit at Rs 721.89 crore for the second quarter ended September 30.
Oct 29, 2015, 20:30 PM IST
Dr Reddy's, BioMarin settle patent litigation on Kuvan tablets
The California-based BioMarin Pharmaceutical has entered into a settlement agreement with Dr Reddy's Laboratories to resolve patent litigation in the US regarding Kuvan, the former's 100mg oral tablets.
Sep 21, 2015, 12:41 PM IST
Dr Reddy's to market three Amgen drugs in India
Dr Reddy's Laboratories on Thursday said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.
Aug 06, 2015, 12:57 PM IST
Dr Reddy's shares gain over 5% on Q1 net jump
At the NSE, shares of the company rose by 5.4 percent to close at Rs 3,913.10.
Jul 30, 2015, 17:39 PM IST
Dr Reddy's Laboratories working on 18 new drug applications
Drugmaker Dr Reddy's Laboratories Limited is working on 18 new drug applications, including the three NDAs it has already filed with the US Food and Drug Administration, and expects 2 more drugs to go for approvals before 2018.
Jun 21, 2015, 21:32 PM IST
AstraZeneca, Dr Reddy's ink diabetes drug distribution pact
AstraZeneca Pharma India and Dr Reddy's Laboratories on Friday entered into a distribution agreement for two drugs -- Riax and Riax-M -- used for treatment of diabetes in India.
May 29, 2015, 19:32 PM IST
Dr Reddy's scrip gains nearly 4% on launching drug
Shares of Dr Reddy's Laboratories Monday rose by nearly 4 percent after the company launched Somazina, a drug used for treating those who have suffered stroke, in India.
May 18, 2015, 20:43 PM IST
Dr Reddy's Lab to enter Japanese market through a partner
Pharmaceutical major Dr Reddy's Laboratories Tuesday said it has plans to enter Japanese market through partnerships for specific products.
May 12, 2015, 19:37 PM IST
Dr Reddy's to buy UCB's select brands for Rs 800 crore
"The acquired business is being sold on a slump sale basis. The revenues of the acquired business is approximately Rs 150 crore for the calendar year 2014," it added.
Apr 01, 2015, 14:43 PM IST
Dr Reddy's shares up on Hepatitis C drug launch plan
Shares of Dr Reddy's Laboratories on Tuesday settled with gains of nearly 2 percent after the firm said it is planning to launch Hepatitis C drug in the country, following which its market capitalisation rose Rs 1,000 crore.
Mar 24, 2015, 19:08 PM IST
Attorney Generals of Texas, California probe DRL's drug pricing mechanism
Attorney Generals of Texas and California have separately sought information on pricing of some drugs sold by Dr Reddy's Laboratories in the US, according to the latest filing for the drug maker with SEC.
Feb 25, 2015, 10:50 AM IST
HC stays suspension order of Maha FDA on Dr Reddy's C&F agent
Dr Reddy's Laboratories on Friday said the Bombay High Court has granted an interim stay on an order issued by the Maharashtra drug controller (FDA) for a one-month suspension of wholesale licence of the company's clearing and forwarding agent in Bhiwandi near Thane.
Jan 09, 2015, 14:18 PM IST
Dr Reddy's acquires Habitrol brand
City-based drugmaker Dr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.
Dec 19, 2014, 16:02 PM IST
Dr Reddy's launches generic anti-viral tablets in US market
The tablets are generic version of Roche's Valcyte tablets, it added.
Dec 16, 2014, 13:42 PM IST
Dr Reddy's plant gets USFDA fiat on suspected lapses
The company is in the process of responding to the FDA's observations, a Dr Reddy's spokesperson said.
Nov 26, 2014, 19:44 PM IST
Dr Reddy's Q2 net down 17% at Rs 574.1 cr
Net income during the period under review stood at Rs 3,587.81 crore as against Rs 3,357.45 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.
Oct 29, 2014, 16:07 PM IST
